Complete mesogastric excision for locally advanced gastric cancer: short-term outcomes of a randomized clinical trial
Authors:
Open Access
- 1 March 2021
- journal article
- research article
- Published by Elsevier in Cell Reports Medicine
- Vol. 2 (3) , 100217
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81372324, 81874185)
This publication has 28 references indexed in Scilit:
- An Optimal Surgical Approach for Suprapancreatic Area Dissection in Laparoscopic D2 Gastrectomy with Complete Mesogastric ExcisionJournal of Gastrointestinal Surgery, 2020
- Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric CancerJAMA, 2019
- The importance of the mesofascial interface in complete mesocolic excisionThe Surgeon, 2017
- Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled TrialJournal of Clinical Oncology, 2016
- Short-term outcomes of laparoscopic D2 lymphadenectomy with complete mesogastrium excision for advanced gastric cancerSurgical Endoscopy, 2016
- Efficacy of laparoscopic subtotal gastrectomy with D2 lymphadenectomy for locally advanced gastric cancer: the protocol of the KLASS-02 multicenter randomized controlled clinical trialBMC Cancer, 2015
- Mesogastrium: A fifth route of metastasis in gastric cancer?Medical Hypotheses, 2013
- Japanese gastric cancer treatment guidelines 2010 (ver. 3)Gastric Cancer, 2011
- Proposed classification of complications of surgery with examples of utility in cholecystectomy.1992
- RECURRENCE AND SURVIVAL AFTER TOTAL MESORECTAL EXCISION FOR RECTAL CANCERThe Lancet, 1986